tiprankstipranks
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
Want to see JANX full AI Analyst Report?

Janux Therapeutics Inc (JANX) Stock Forecast & Price Target

717 Followers
See the Price Targets and Ratings of:

JANX Analyst Ratings

Strong Buy
15Ratings
Strong Buy
13 Buy
1 Hold
1 Sell
Based on 15 analysts giving stock ratings to
Janux
Therapeutics Inc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

JANX Stock 12 Month Forecast

Average Price Target

$43.15
▲(172.78% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Janux Therapeutics Inc in the last 3 months. The average price target is $43.15 with a high forecast of $100.00 and a low forecast of $14.00. The average price target represents a 172.78% change from the last price of $15.82.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","101":"$101","34.25":"$34.3","56.5":"$56.5","78.75":"$78.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$100.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":43.15384615384615,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$43.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,34.25,56.5,78.75,101],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.51,21.086153846153845,27.662307692307692,34.238461538461536,40.81461538461538,47.39076923076922,53.966923076923074,60.54307692307692,67.11923076923077,73.69538461538461,80.27153846153846,86.8476923076923,93.42384615384616,{"y":100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.51,16.71337278106509,18.916745562130178,21.120118343195266,23.323491124260357,25.526863905325442,27.730236686390533,29.933609467455625,32.13698224852071,34.3403550295858,36.543727810650886,38.74710059171598,40.95047337278107,{"y":43.15384615384615,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.51,14.47076923076923,14.43153846153846,14.392307692307693,14.353076923076923,14.313846153846153,14.274615384615384,14.235384615384616,14.196153846153846,14.156923076923077,14.117692307692307,14.07846153846154,14.03923076923077,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.81,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.05,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.01,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.22,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.56,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.86,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.71,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.99,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.99,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.42,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.51,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$100.00Average Price Target$43.15Lowest Price Target$14.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wedbush Analyst forecast on JANX
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$45$36
Buy
127.56%
Upside
Reiterated
04/28/26
Janux Therapeutics Inc (JANX) Receives a Buy from Wedbush
JonesTrading Analyst forecast on JANX
JonesTrading
JonesTrading
$50$28
Buy
76.99%
Upside
Reiterated
04/28/26
Janux Therapeutics price target lowered to $28 from $50 at JonesResearchJanux Therapeutics price target lowered to $28 from $50 at JonesResearch
Bank of America Securities Analyst forecast on JANX
Bank of America Securities
Bank of America Securities
$29$24
Buy
51.71%
Upside
Reiterated
04/28/26
Together, these changes result in a $24 PO (from $29) and we reiterate Buy.
Stifel Nicolaus Analyst forecast on JANX
Stifel Nicolaus
Stifel Nicolaus
$38
Buy
140.20%
Upside
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN), Eli Lilly & Co (NYSE: LLY) and Janux Therapeutics Inc (NASDAQ: JANX)
William Blair Analyst forecast on JANX
William Blair
William Blair
Buy
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Janux Therapeutics Inc (NASDAQ: JANX)
H.C. Wainwright Analyst forecast on JANX
H.C. Wainwright
H.C. Wainwright
$45
Buy
184.45%
Upside
Reiterated
04/22/26
Advancing PSMA Franchise and Validating TRACTr Platform Underpin Buy Rating on Janux Therapeutics
Barclays Analyst forecast on JANX
Barclays
Barclays
$29$14
Sell
-11.50%
Downside
Downgraded
04/20/26
Janux Therapeutics downgraded to Underweight from Overweight at BarclaysJanux Therapeutics downgraded to Underweight from Overweight at Barclays
TD Cowen Analyst forecast on JANX
TD Cowen
TD Cowen
Buy
Reiterated
04/20/26
UBS
$57$15
Hold
-5.18%
Downside
Downgraded
04/15/26
Janux Therapeutics downgraded to Neutral from Buy at UBSJanux Therapeutics downgraded to Neutral from Buy at UBS
Evercore ISI Analyst forecast on JANX
Evercore ISI
Evercore ISI
$25$23
Buy
45.39%
Upside
Reiterated
04/13/26
Janux Therapeutics price target lowered to $23 from $25 at Evercore ISIJanux Therapeutics price target lowered to $23 from $25 at Evercore ISI
Truist Financial Analyst forecast on JANX
Truist Financial
Truist Financial
$100$80
Buy
405.69%
Upside
Reiterated
03/03/26
Analysts Offer Insights on Healthcare Companies: Elevance Health (NYSE: ELV), Veeva Systems (NYSE: VEEV) and Janux Therapeutics Inc (NASDAQ: JANX)
LifeSci Capital Analyst forecast on JANX
LifeSci Capital
LifeSci Capital
$60
Buy
279.27%
Upside
Reiterated
02/27/26
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
Piper Sandler Analyst forecast on JANX
Piper Sandler
Piper Sandler
$30
Buy
89.63%
Upside
Reiterated
02/27/26
Piper Sandler Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)
Cantor Fitzgerald Analyst forecast on JANX
Cantor Fitzgerald
Cantor Fitzgerald
$150$100
Buy
532.11%
Upside
Reiterated
02/26/26
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX), Progyny (NASDAQ: PGNY) and Concentra Group Holdings Parent, Inc. (NYSE: CON)
Guggenheim Analyst forecast on JANX
Guggenheim
Guggenheim
$72$68
Buy
329.84%
Upside
Reiterated
02/26/26
Janux Therapeutics price target lowered to $68 from $72 at GuggenheimJanux Therapeutics price target lowered to $68 from $72 at Guggenheim
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wedbush Analyst forecast on JANX
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$45$36
Buy
127.56%
Upside
Reiterated
04/28/26
Janux Therapeutics Inc (JANX) Receives a Buy from Wedbush
JonesTrading Analyst forecast on JANX
JonesTrading
JonesTrading
$50$28
Buy
76.99%
Upside
Reiterated
04/28/26
Janux Therapeutics price target lowered to $28 from $50 at JonesResearchJanux Therapeutics price target lowered to $28 from $50 at JonesResearch
Bank of America Securities Analyst forecast on JANX
Bank of America Securities
Bank of America Securities
$29$24
Buy
51.71%
Upside
Reiterated
04/28/26
Together, these changes result in a $24 PO (from $29) and we reiterate Buy.
Stifel Nicolaus Analyst forecast on JANX
Stifel Nicolaus
Stifel Nicolaus
$38
Buy
140.20%
Upside
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN), Eli Lilly & Co (NYSE: LLY) and Janux Therapeutics Inc (NASDAQ: JANX)
William Blair Analyst forecast on JANX
William Blair
William Blair
Buy
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Janux Therapeutics Inc (NASDAQ: JANX)
H.C. Wainwright Analyst forecast on JANX
H.C. Wainwright
H.C. Wainwright
$45
Buy
184.45%
Upside
Reiterated
04/22/26
Advancing PSMA Franchise and Validating TRACTr Platform Underpin Buy Rating on Janux Therapeutics
Barclays Analyst forecast on JANX
Barclays
Barclays
$29$14
Sell
-11.50%
Downside
Downgraded
04/20/26
Janux Therapeutics downgraded to Underweight from Overweight at BarclaysJanux Therapeutics downgraded to Underweight from Overweight at Barclays
TD Cowen Analyst forecast on JANX
TD Cowen
TD Cowen
Buy
Reiterated
04/20/26
UBS
$57$15
Hold
-5.18%
Downside
Downgraded
04/15/26
Janux Therapeutics downgraded to Neutral from Buy at UBSJanux Therapeutics downgraded to Neutral from Buy at UBS
Evercore ISI Analyst forecast on JANX
Evercore ISI
Evercore ISI
$25$23
Buy
45.39%
Upside
Reiterated
04/13/26
Janux Therapeutics price target lowered to $23 from $25 at Evercore ISIJanux Therapeutics price target lowered to $23 from $25 at Evercore ISI
Truist Financial Analyst forecast on JANX
Truist Financial
Truist Financial
$100$80
Buy
405.69%
Upside
Reiterated
03/03/26
Analysts Offer Insights on Healthcare Companies: Elevance Health (NYSE: ELV), Veeva Systems (NYSE: VEEV) and Janux Therapeutics Inc (NASDAQ: JANX)
LifeSci Capital Analyst forecast on JANX
LifeSci Capital
LifeSci Capital
$60
Buy
279.27%
Upside
Reiterated
02/27/26
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
Piper Sandler Analyst forecast on JANX
Piper Sandler
Piper Sandler
$30
Buy
89.63%
Upside
Reiterated
02/27/26
Piper Sandler Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)
Cantor Fitzgerald Analyst forecast on JANX
Cantor Fitzgerald
Cantor Fitzgerald
$150$100
Buy
532.11%
Upside
Reiterated
02/26/26
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX), Progyny (NASDAQ: PGNY) and Concentra Group Holdings Parent, Inc. (NYSE: CON)
Guggenheim Analyst forecast on JANX
Guggenheim
Guggenheim
$72$68
Buy
329.84%
Upside
Reiterated
02/26/26
Janux Therapeutics price target lowered to $68 from $72 at GuggenheimJanux Therapeutics price target lowered to $68 from $72 at Guggenheim
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Janux Therapeutics Inc

3 Months
xxx
Success Rate
6/12 ratings generated profit
50%
Average Return
+7.42%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.42% per trade.
1 Year
Swayampakula RamakanthH.C. Wainwright
Success Rate
4/17 ratings generated profit
24%
Average Return
+18.51%
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 23.53% of your transactions generating a profit, with an average return of +18.51% per trade.
2 Years
xxx
Success Rate
4/17 ratings generated profit
24%
Average Return
-16.30%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 23.53% of your transactions generating a profit, with an average return of -16.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

JANX Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
25
27
24
14
17
Buy
11
10
12
5
7
Hold
1
2
1
1
1
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
37
39
37
20
26
In the current month, JANX has received 24 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. JANX average Analyst price target in the past 3 months is 43.15.
Each month's total comprises the sum of three months' worth of ratings.

JANX Financial Forecast

JANX Earnings Forecast

Next quarter’s earnings estimate for JANX is -$0.55 with a range of -$0.93 to -$0.36. The previous quarter’s EPS was -$0.51. JANX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year JANX has Performed in-line its overall industry.
Next quarter’s earnings estimate for JANX is -$0.55 with a range of -$0.93 to -$0.36. The previous quarter’s EPS was -$0.51. JANX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year JANX has Performed in-line its overall industry.

JANX Sales Forecast

Next quarter’s sales forecast for JANX is $4.36M with a range of $0.00 to $15.00M. The previous quarter’s sales results were $0.00. JANX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year JANX has Performed in-line its overall industry.
Next quarter’s sales forecast for JANX is $4.36M with a range of $0.00 to $15.00M. The previous quarter’s sales results were $0.00. JANX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year JANX has Performed in-line its overall industry.

JANX Stock Forecast FAQ

What is JANX’s average 12-month price target, according to analysts?
Based on analyst ratings, Janux Therapeutics Inc’s 12-month average price target is 43.15.
    What is JANX’s upside potential, based on the analysts’ average price target?
    Janux Therapeutics Inc has 172.78% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is JANX a Buy, Sell or Hold?
          Janux Therapeutics Inc has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 1 sell ratings.
            What is Janux Therapeutics Inc’s price target?
            The average price target for Janux Therapeutics Inc is 43.15. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $100.00 ,the lowest forecast is $14.00. The average price target represents 172.78% Increase from the current price of $15.82.
              What do analysts say about Janux Therapeutics Inc?
              Janux Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of JANX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.